Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if IMCR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
35 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
136 filers reported a long position in IMCR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | $181.7M | 5.7M | +21.6% |
| RTW INVESTMENTS, LP | $154.6M | 4.9M | Unchanged |
| FMR LLC | $136.8M | 4.3M | -10.8% |
| PRIMECAP MANAGEMENT CO/CA/ | $115.5M | 3.6M | -1.5% |
| Bellevue Group AG | $88.5M | 2.8M | -0.3% |
| TANG CAPITAL MANAGEMENT LLC | $84.1M | 2.6M | Unchanged |
| Vestal Point Capital, LP | $57.2M | 1.8M | -34.9% |
| TWO SIGMA INVESTMENTS, LP | $52.4M | 1.6M | +61.5% |
| MILLENNIUM MANAGEMENT LLC | $50.7M | 1.6M | +29.1% |
| ARMISTICE CAPITAL, LLC | $45.3M | 1.4M | +20.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.